Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America

Ankeet S. Bhatt; Eric D. Adler; Nancy M. Albert; Anelechi Anyanwu; Nahid Bhadelia; Leslie T. Cooper; Ashish Correa; Ersilia M. Defilippis; Emer Joyce; Andrew J. Sauer; Scott D. Solomon; Orly Vardeny; Clyde Yancy; Anuradha Lala

doi:10.1016/j.cardfail.2021.08.013

Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America

Ankeet S. Bhatt, Eric D. Adler, Nancy M. Albert, Anelechi Anyanwu, Nahid Bhadelia, Leslie T. Cooper, Ashish Correa, Ersilia M. Defilippis, Emer Joyce, Andrew J. Sauer, Scott D. Solomon, Orly Vardeny, Clyde Yancy, Anuradha Lala^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	93-112
Number of pages	20
Journal	Journal of Cardiac Failure
Volume	28
Issue number	1
DOIs	https://doi.org/10.1016/j.cardfail.2021.08.013
State	Published - Jan 2022

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cardfail.2021.08.013

Cite this

Bhatt, A. S., Adler, E. D., Albert, N. M., Anyanwu, A., Bhadelia, N., Cooper, L. T., Correa, A., Defilippis, E. M., Joyce, E., Sauer, A. J., Solomon, S. D., Vardeny, O., Yancy, C., & Lala, A. (2022). Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. Journal of Cardiac Failure, 28(1), 93-112. https://doi.org/10.1016/j.cardfail.2021.08.013

@article{9201b20e0a9b4beeb2dbc62f30b4d580,

title = "Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America",

author = "Bhatt, {Ankeet S.} and Adler, {Eric D.} and Albert, {Nancy M.} and Anelechi Anyanwu and Nahid Bhadelia and Cooper, {Leslie T.} and Ashish Correa and Defilippis, {Ersilia M.} and Emer Joyce and Sauer, {Andrew J.} and Solomon, {Scott D.} and Orly Vardeny and Clyde Yancy and Anuradha Lala",

note = "Funding Information: Dr Bhatt reports consulting fees from Sanofi Pasteur, Verve Therapeutics, and Clarivate and is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL007604. Dr Adler has received consulting fees from Medtronic and Abbott. Dr Bhadelia has received research grants from NIH Fogarty Center, has received speaking honoraria from Agilent Technologies and Health Industry Distributors Association. Dr Sauer has received research grant funding and consulting or speaking honoraria from Abbott, Boston Scientific, Medtronic, Edwards, PreCARDIA, and Bioventrix. Dr Solomon has received research grants from Alnylam, Amgen, AstraZeneca, Bellerophon, Bayer, BMS, Celladon, Cytokinetics, Eidos, Gilead, GSK, Ionis, Lone Star Heart, Mesoblast, MyoKardia, NIH/NHLBI, Neurotronik, Novartis, Respicardia, Sanofi Pasteur, Theracos, and has consulted for Akros, Alnylam, Amgen, Arena, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi-Sankyo, Gilead, GSK, Ironwood, Merck, Myokardia, Novartis, Roche, Takeda, Theracos, Quantum Genetics, Cardurion, AoBiome, Janssen, Cardiac Dimensions, Tenaya, Sanofi-Pasteur, Dinaqor, and Tremeau. Dr Vardeny reported research support from the National Institutes of Health and consulting with Sanofi-Pasteur Inc. Dr Lala reports speaker honoraria from Zoll Medical and Abbott. She serves on the DSMB for Suquana Medical and on an advisory board for Bioventrix. All other authors report no disclosures relevant to this article.",

year = "2022",

month = jan,

doi = "10.1016/j.cardfail.2021.08.013",

language = "English (US)",

volume = "28",

pages = "93--112",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Churchill Livingstone",

number = "1",

}

Bhatt, AS, Adler, ED, Albert, NM, Anyanwu, A, Bhadelia, N, Cooper, LT, Correa, A, Defilippis, EM, Joyce, E, Sauer, AJ, Solomon, SD, Vardeny, O, Yancy, C & Lala, A 2022, 'Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America', Journal of Cardiac Failure, vol. 28, no. 1, pp. 93-112. https://doi.org/10.1016/j.cardfail.2021.08.013

TY - JOUR

T1 - Coronavirus Disease-2019 and Heart Failure

T2 - A Scientific Statement From the Heart Failure Society of America

AU - Bhatt, Ankeet S.

AU - Adler, Eric D.

AU - Albert, Nancy M.

AU - Anyanwu, Anelechi

AU - Bhadelia, Nahid

AU - Cooper, Leslie T.

AU - Correa, Ashish

AU - Defilippis, Ersilia M.

AU - Joyce, Emer

AU - Sauer, Andrew J.

AU - Solomon, Scott D.

AU - Vardeny, Orly

AU - Yancy, Clyde

AU - Lala, Anuradha

N1 - Funding Information: Dr Bhatt reports consulting fees from Sanofi Pasteur, Verve Therapeutics, and Clarivate and is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL007604. Dr Adler has received consulting fees from Medtronic and Abbott. Dr Bhadelia has received research grants from NIH Fogarty Center, has received speaking honoraria from Agilent Technologies and Health Industry Distributors Association. Dr Sauer has received research grant funding and consulting or speaking honoraria from Abbott, Boston Scientific, Medtronic, Edwards, PreCARDIA, and Bioventrix. Dr Solomon has received research grants from Alnylam, Amgen, AstraZeneca, Bellerophon, Bayer, BMS, Celladon, Cytokinetics, Eidos, Gilead, GSK, Ionis, Lone Star Heart, Mesoblast, MyoKardia, NIH/NHLBI, Neurotronik, Novartis, Respicardia, Sanofi Pasteur, Theracos, and has consulted for Akros, Alnylam, Amgen, Arena, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi-Sankyo, Gilead, GSK, Ironwood, Merck, Myokardia, Novartis, Roche, Takeda, Theracos, Quantum Genetics, Cardurion, AoBiome, Janssen, Cardiac Dimensions, Tenaya, Sanofi-Pasteur, Dinaqor, and Tremeau. Dr Vardeny reported research support from the National Institutes of Health and consulting with Sanofi-Pasteur Inc. Dr Lala reports speaker honoraria from Zoll Medical and Abbott. She serves on the DSMB for Suquana Medical and on an advisory board for Bioventrix. All other authors report no disclosures relevant to this article.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85117812096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117812096&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2021.08.013

DO - 10.1016/j.cardfail.2021.08.013

M3 - Article

C2 - 34481067

AN - SCOPUS:85117812096

SN - 1071-9164

VL - 28

SP - 93

EP - 112

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 1

ER -

Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this